Healthcare Triangle (HCTI) has announced an important financial maneuver, confirming a 1-for-60 reverse stock split of its common stock. This strategic decision will go into effect at 12:01 a.m. Eastern Time on February 10, 2026. Following this split, the company’s shares will begin trading on the Nasdaq Capital Market under the existing symbol “HCTI,” contingent upon approval from the Depository Trust Company and the Nasdaq.
This action, which received the nod from stockholders during a special meeting on February 2, 2026, is aimed at enhancing the share price of Healthcare Triangle’s common stock. The reverse split is a key element of the company’s broader strategy to ensure compliance with Nasdaq’s minimum bid price requirement, which mandates a share price of at least $1.00.
Investors and market watchers are particularly keen on this development, as the reverse stock split could potentially bolster investor confidence and improve liquidity. The company believes that by increasing the price per share, it can better position itself within the increasingly competitive healthcare technology market.
As the effective date approaches, all eyes will be on how this strategic move influences Healthcare Triangle’s market performance and investor sentiment in the coming months.
